Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1985-03-08
1995-05-09
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 3166
Patent
active
054139953
ABSTRACT:
A lyophilized pharmaceutical solid composition containing cyclophosphamide for reconstitution with water to provide a solution for oral or parenteral administration. This lyophilized cyclophosphamide solid composition demonstrates improved stability, solubility characteristics and enhanced appearance compared with currently available dry powder pre-mix compositions of cyclophosphamide. The lyophilized solid composition contains about 20 parts by weight of cyclophosphamide, about 11/4-2 parts by weight of water and from about 10-85 parts by weight of excipient which is comprised mainly of mannitol. Processes for making the composition are disclosed.
REFERENCES:
patent: 3018302 (1962-01-01), Arnold et al.
patent: 3732340 (1973-05-01), Arnold et al.
Brooke, et al., American Journal of Hospital Pharmacy, 32:44-45 (1975).
Lachman, et al., "The Theory and Practice of Industrial Pharmacy", 2nd Ed., Lea & Febiger, Philadelphia, Pa., pp. 521-524 (1976).
Anon., "Remington's Pharmaceutical Sciences", 15th Ed., Mack Publishing Co., Easton, Pa., pp. 1483-1485 (1975).
Alexander Robert L.
Bequette Robert J.
Kensler Terry T.
Scott Joseph A.
Goldberg Jerome D.
Mead Johnson & Company
Ryan Richard P.
Uloth Robert H.
LandOfFree
Lyophilized cyclophosphamide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lyophilized cyclophosphamide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lyophilized cyclophosphamide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705435